| Objective: To investigate the budesonide/formoterol (Symbicort) whether it's ability to effect rapidly and improve lung function effectively in children with bronchial asthma, as well as to alleviate the symptoms of acute attack.Methods: 20 participants were selected according to the standard diagnosis criteria of asthma, and in the course of an acute attack. Pulmonary function test and wheezing conditions were investigated and its improvement was measured at 5, 15 and 30 minutes post-inhalation of symbicort with 2puff.Results: Inhalation therapy with Symbicort, it's taking effect within 30 minutes in all cases. Lung function was improved, bronchial dilation test was positive, and it reduced the wheezing sound over lung after inhalation of the drug. In 20 children, 15 cases showed Symbicort taking effect within 5 minutes, their lung function test improved & bronchial dilation test were positive but it's taking effect within 15 minutes in the other 5 cases, their lung function test improved & bronchial dilation test were positive as well.Conclusion: The Symbicort can be used as maintenance and reliever inhalation therapy in children with acute exacerbations of bronchial asthma. |
PDF Full Text Request